The White House released a health care plan Jan. 15 addressing drug prices, health insurance premiums and price transparency efforts. The plan includes codifying the administration’s “most favored nation” agreements recently reached with certain drugmakers, where companies must offer Americans the lowest cost paid for the same medications in other countries. It also calls for sending subsidies directly to Americans instead of insurance companies and funding cost-sharing reductions to reduce premiums. The plan would also require health insurers to publish rate and coverage comparisons on their websites “in plain English — not industry jargon” for consumers. In addition, the plan calls for any health provider or insurer accepting Medicare or Medicaid to “prominently” post their pricing and fees. 

Headline
The AHA Aug. 17 provided comments to the Centers for Medicare & Medicaid Services on its proposed rule to codify in regulation the Medicare Drug Price…
Headline
The 5th U.S. Circuit Court of Appeals Aug. 11 ruled to vacate certain regulations implementing how the No Surprises Act qualifying payment amount is calculated…
Headline
Guidance on the implementation timeline for the No Surprises Act independent dispute resolution operations final rule was released Aug. 7 by the Departments of…
Headline
The U.S. District Court for the Eastern District of Pennsylvania Aug. 5 granted a motion for the AHA and the Hospital and Healthsystem Association of…
Headline
The Department of Labor July 22 released a proposed rule to modernize how group health plans deliver required disclosures. The proposal would create a safe…
Headline
The AHA provided comments July 21 to the Senate Committee on Health, Education, Labor and Pensions on price transparency, nursing workforce and rural…